GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Stock Based Compensation

Starton Therapeutics (Starton Therapeutics) Stock Based Compensation : $2.11 Mil (TTM As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Stock Based Compensation?

Starton Therapeutics's Stock Based Compensation for the three months ended in Jun. 2023 was $1.32 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was $2.11 Mil.


Starton Therapeutics Stock Based Compensation Historical Data

The historical data trend for Starton Therapeutics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Stock Based Compensation Chart

Starton Therapeutics Annual Data
Trend Mar21 Mar22 Mar23
Stock Based Compensation
1.31 2.40 3.34

Starton Therapeutics Quarterly Data
Mar21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Stock Based Compensation Get a 7-Day Free Trial 0.76 0.79 - 0.79 1.32

Starton Therapeutics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.11 Mil.


Starton Therapeutics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Starton Therapeutics (Starton Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
215 College Road, Suite No.300, Paramus, NJ, USA, 07652
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines